AGP news and notes AGP Limited

What SuperX wrote about AGP

1. The price fell 0.13% on 13 Nov. The pharmaceuticals sector median fell 0.2% today, with 10 of 15 scrips down.

2. The annual results for the period ending 31 Dec are not yet filed. Last year they were filed on 24 Mar.

3. Latest results, filed 30 Oct, show EPS of 1.13 against 2.4 a year ago, down 52.92%.

Written by SuperX’s analyst desk from SuperX’s own figures, from the close of 13 Nov 2026. Each number was checked against those figures. Not advice.

What changed for AGP, newest first

• 13 Nov 2026Closed 156.37, -0.13%. Volume 62,386, 0.2 times the average of the 30 sessions before it, 272,947.
• 12 Nov 2026Margin financing (MTS) open on AGP: 216,227 shares.
• 10 Nov 2026Trend read changed to sideways: above the 50-day average, below the 200-day; down 17.0% over 3 months.
• 30 Oct 2026Quarter ended 30 Sep 2026: earnings per share Rs 1.13, sales Rs 4.2 bn, down 52.9% on the same quarter a year before.
• NextAnnual results (to 31 Dec 2026) expected 5 Feb 2027 – 29 Mar 2027, a projection. An estimate from the dates of the last 8 filings.

As of the close of 13 Nov 2026. Closes and notices: PSX. Margin financing: NCCPL. Trend read: SuperX, from daily closes. Volume: against the average of the 30 sessions before the last. Next results: an estimate from the dates of the last 8 filings. Not advice.

News about AGP

• 22 Oct 2026AGP highlights digital procurement as key to transparent governance · The Nation
• 16 Sep 2026IK hospital transfer pleas: SC seeks AGP’s views on jurisdiction · Business Recorder

From 16 Sep 2026 to 22 Oct 2026. A story is listed here when its headline names the company and names three companies or fewer. Headlines are the publishers’ own words and link to them.